Skip to main content
EN
Go
Healthcare professional
Logo Equilibrium
X
Home
About EquilYbrium
Our Mission
Steering Committee members
Immunodeficiencies
Primary Immunodeficiencies
ADVANCED CARE IN PID: From birth to adulthood: LFB Symposium IPIC 2015
THE IMMUNOLOGIST CONSULTATION; Recognizing the signs of X-linked agammaglobulinemia
NEW INSIGHTS IN THE USE OF INTRAVENOUS IMMUNOGLOBULINS: How to enhance PID patients clinical outcomes ?
Secondary Immunodeficiencies
SID IN A HEART TRANSPLANT PATIENT
Immunomodulation
Guillain-Barré Syndrome (GBS)
Guillain Barré Syndrome : From diagnosis to treatment
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Multifocal Motor neuropathy (MMN)
Other therapeutic uses
Inflammatory Myopathies
Sitemap
Home
About EquilYbrium
Our Mission
Steering Committee members
Immunodeficiencies
Primary Immunodeficiencies
Secondary Immunodeficiencies
Immunomodulation
Guillain-Barré Syndrome (GBS)
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Multifocal Motor neuropathy (MMN)
Other therapeutic uses
Inflammatory Myopathies
Home
About EquilYbrium
Our Mission
Steering Committee members
Immunodeficiencies
Primary Immunodeficiencies
ADVANCED CARE IN PID: From birth to adulthood: LFB Symposium IPIC 2015
THE IMMUNOLOGIST CONSULTATION; Recognizing the signs of X-linked agammaglobulinemia
NEW INSIGHTS IN THE USE OF INTRAVENOUS IMMUNOGLOBULINS: How to enhance PID patients clinical outcomes ?
Secondary Immunodeficiencies
SID IN A HEART TRANSPLANT PATIENT
Immunomodulation
Guillain-Barré Syndrome (GBS)
Guillain Barré Syndrome : From diagnosis to treatment
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Multifocal Motor neuropathy (MMN)
Other therapeutic uses
Inflammatory Myopathies
×
The use of IVIG in these indications are under the responsibility of the physician.
I accept ▸
